Not all individuals with CLL call for therapy. Inspite of all current developments, the iwCLL even now endorses watchful observation for people with asymptomatic illness.86 This suggestion relies on not less than two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Partisipasi aktif dari https://chelwoodx853qxg0.digitollblog.com/profile